REFRACTORY
Clinical trials for REFRACTORY explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY trials appear
Sign up with your email to follow new studies for REFRACTORY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gentle laser tested to save sight from diabetes
Disease control Recruiting nowThis study is testing a gentle, pulsed laser treatment for diabetic macular edema, a common cause of vision loss where fluid swells the center of the eye. It will compare how well the laser works for people trying it for the first time versus those whose swelling hasn't improved …
Matched conditions: REFRACTORY
Sponsor: The General Authority for Teaching Hospitals and Institutes • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Florida launches AI cancer fight: custom treatments for tough cases
Disease control Recruiting nowThis Florida-based study is testing a new AI-powered approach to find personalized treatments for cancer patients whose disease has returned or stopped responding to standard therapies. It aims to serve 210 patients, with a special focus on reaching children and underserved commu…
Matched conditions: REFRACTORY
Phase: NA • Sponsor: First Ascent Biomedical Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New 'Living Drug' trial offers hope for Tough-to-Treat lupus
Disease control Recruiting nowThis is an early-stage trial testing a new type of personalized cell therapy called MC-1-50 for adults with severe, treatment-resistant lupus. The main goal is to check the safety and side effects of three different doses of these specially engineered immune cells. Researchers wi…
Matched conditions: REFRACTORY
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Engineered immune cells target stubborn lymphoma in new trial
Disease control Recruiting nowThis study is testing a new type of cell therapy for Hodgkin lymphoma that has come back or hasn't responded to standard treatments. Researchers are modifying a patient's own immune cells to better find and attack the cancer cells. The trial aims to find a safe dose and see how w…
Matched conditions: REFRACTORY
Phase: PHASE1, PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC